Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quinten Goovaerts

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature|October 11, 2023
Structures illustrate step-by-step mitochondrial transcription initiationQuinten Goovaerts, Jiayu Shen, Brent De Wijngaert, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Human mitochondrial RNA polymerase structures reveal transcription start-site and slippage mechanismJiayu Shen, Quinten Goovaerts, Yogeeshwar Ajjugal, et al.
STAR Protocols|January 23, 2026
Protocol to investigate human mitochondrial transcription initiation by integrating biochemical and cryo-EM approachesYogeeshwar Ajjugal, Quinten Goovaerts, Jiayu Shen, et al.
Molecular Cell|July 25, 2025
Human mitochondrial RNA polymerase structures reveal transcription start site and slippage mechanismJiayu Shen, Quinten Goovaerts, Yogeeshwar Ajjugal, et al.
Research Square|November 24, 2025
Structural basis for selective remdesivir incorporation by SARS-CoV-2 polymerase, and S759A resistanceKalyan Das, Calvin Gordon, Mizar Oliva, et al.
Communications Biology|March 14, 2026
Preferential remdesivir triphosphate incorporation by SARS-CoV-2 polymerase is altered to ATP by the S759A mutationCalvin J Gordon, Mizar F Oliva, Hery W Lee, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Structural basis for selective remdesivir incorporation by SARS-CoV-2 RNA polymerase, and S759A resistanceCalvin J Gordon, Mizar F Oliva, Hery W Lee, et al.
Gastroenterology|November 24, 2024
A Pangenotypic Hepatitis E Virus Replication Inhibitor With High Potency in a Rat Infection ModelXin Zhang, Mara Klöhn, Sivi Ouwerkerk-Mahadevan, et al.
Plos Pathogens|February 11, 2025
A guanidine-based coronavirus replication inhibitor which targets the nsp15 endoribonuclease and selects for interferon-susceptible mutant virusesBenjamin Van Loy, Eugènia Pujol, Kenichi Kamata, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature|October 11, 2023
Structures illustrate step-by-step mitochondrial transcription initiationQuinten Goovaerts, Jiayu Shen, Brent De Wijngaert, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Human mitochondrial RNA polymerase structures reveal transcription start-site and slippage mechanismJiayu Shen, Quinten Goovaerts, Yogeeshwar Ajjugal, et al.
STAR Protocols|January 23, 2026
Protocol to investigate human mitochondrial transcription initiation by integrating biochemical and cryo-EM approachesYogeeshwar Ajjugal, Quinten Goovaerts, Jiayu Shen, et al.
Molecular Cell|July 25, 2025
Human mitochondrial RNA polymerase structures reveal transcription start site and slippage mechanismJiayu Shen, Quinten Goovaerts, Yogeeshwar Ajjugal, et al.
Research Square|November 24, 2025
Structural basis for selective remdesivir incorporation by SARS-CoV-2 polymerase, and S759A resistanceKalyan Das, Calvin Gordon, Mizar Oliva, et al.
Communications Biology|March 14, 2026
Preferential remdesivir triphosphate incorporation by SARS-CoV-2 polymerase is altered to ATP by the S759A mutationCalvin J Gordon, Mizar F Oliva, Hery W Lee, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Structural basis for selective remdesivir incorporation by SARS-CoV-2 RNA polymerase, and S759A resistanceCalvin J Gordon, Mizar F Oliva, Hery W Lee, et al.
Gastroenterology|November 24, 2024
A Pangenotypic Hepatitis E Virus Replication Inhibitor With High Potency in a Rat Infection ModelXin Zhang, Mara Klöhn, Sivi Ouwerkerk-Mahadevan, et al.
Plos Pathogens|February 11, 2025
A guanidine-based coronavirus replication inhibitor which targets the nsp15 endoribonuclease and selects for interferon-susceptible mutant virusesBenjamin Van Loy, Eugènia Pujol, Kenichi Kamata, et al.
Pageof 1